Refine
Year of publication
Document Type
- Preprint (402)
- Article (240)
- Working Paper (1)
Language
- English (643)
Has Fulltext
- yes (643)
Is part of the Bibliography
- no (643)
Keywords
- Heavy Ion Experiments (13)
- Hadron-Hadron scattering (experiments) (11)
- LHC (8)
- Heavy-ion collision (6)
- ALICE (3)
- ALICE experiment (3)
- Hadron-Hadron Scattering (3)
- Charm physics (2)
- Heavy Ions (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- global jets (2)
- helical magnetic fields (2)
- kink-like instability (2)
- particle-in-cell simulations (2)
- pp collisions (2)
- recollimation shocks (2)
- relativistic jets (2)
- 900 GeV (1)
- ACLF (1)
- AGN host galaxies (1)
- ALICE detector (1)
- Anti-nuclei (1)
- Beauty production (1)
- Centrality Class (1)
- Centrality Selection (1)
- Compact astrophysical objects (1)
- Comparison with QCD (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Galaxies and clusters (1)
- HBT (1)
- Hadron production (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-ion collisions (1)
- High-energy astrophysics (1)
- Inclusive spectra (1)
- Intensity interferometry (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- Jets (1)
- Lepton-Nucleon Scattering (experiments) (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Monte Carlo (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Neural network (1)
- Nuclear modification factor (1)
- PYTHIA (1)
- Pb–Pb (1)
- Production Cross Section (1)
- Proton–proton (1)
- Radio continuum emission (1)
- Radio jets (1)
- Rapidity Range (1)
- Relativistic heavy ion physics (1)
- Resolution Parameter (1)
- Single electrons (1)
- Single muons (1)
- Supermassive black holes (1)
- Systematic Uncertainty (1)
- TR (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Trigger (1)
- Very long baseline interferometry (1)
- Xenon-based gas mixture (1)
- acute decompensation (1)
- cirrhosis (1)
- dE/dx (1)
- heavy ion experiments (1)
- kinetic instabilities (1)
- mushroom instability (1)
- organ dysfunction (1)
- organ failure (1)
- polarized radiation (1)
- quark gluon plasma (1)
- signature (1)
- spectra (1)
- the Weibel instability (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (638)
- Frankfurt Institute for Advanced Studies (FIAS) (591)
- Informatik (568)
- Medizin (3)
- Hochschulrechenzentrum (2)
- Biochemie und Chemie (1)
- Center for Financial Studies (CFS) (1)
- House of Finance (HoF) (1)
- Sustainable Architecture for Finance in Europe (SAFE) (1)
- Wirtschaftswissenschaften (1)
Background: Patients with acutely decompensated cirrhosis (AD) may or may not develop acute-on-chronic liver failure (ACLF). ACLF is characterized by high-grade systemic inflammation, organ failures (OF) and high short-term mortality. Although patients with AD cirrhosis exhibit distinct clinical phenotypes at baseline, they have low short-term mortality, unless ACLF develops during follow-up. Because little is known about the association of profile of systemic inflammation with clinical phenotypes of patients with AD cirrhosis, we aimed to investigate a battery of markers of systemic inflammation in these patients.
Methods: Upon hospital admission baseline plasma levels of 15 markers (cytokines, chemokines, and oxidized albumin) were measured in 40 healthy controls, 39 compensated cirrhosis, 342 AD cirrhosis, and 161 ACLF. According to EASL-CLIF criteria, AD cirrhosis was divided into three distinct clinical phenotypes (AD-1: Creatinine<1.5, no HE, no OF; AD-2: creatinine 1.5–2, and or HE grade I/II, no OF; AD-3: Creatinine<1.5, no HE, non-renal OF).
Results: Most markers were slightly abnormal in compensated cirrhosis, but markedly increased in AD. Patients with ACLF exhibited the largest number of abnormal markers, indicating “full-blown” systemic inflammation (all markers). AD-patients exhibited distinct systemic inflammation profiles across three different clinical phenotypes. In each phenotype, activation of systemic inflammation was only partial (30% of the markers). Mortality related to each clinical AD-phenotype was significantly lower than mortality associated with ACLF (p < 0.0001 by gray test). Among AD-patients baseline systemic inflammation (especially IL-8, IL-6, IL-1ra, HNA2 independently associated) was more intense in those who had poor 28-day outcomes (ACLF, death) than those who did not experience these outcomes.
Conclusions: Although AD-patients exhibit distinct profiles of systemic inflammation depending on their clinical phenotypes, all these patients have only partial activation of systemic inflammation. However, those with the most extended baseline systemic inflammation had the highest the risk of ACLF development and death.